In a complex regulatory environment, post-market surveillance is a continuous process that demands precision, adaptability ...
Gilead licences Sprint Bioscience’s pre-clinical TREX1 inhibitor programme, gaining a novel immuno-oncology asset targeting ...
Black Book Pre-Thanksgiving Flash Survey shows expectations for improved stability, leadership continuity, and returns on AI and technology investments NEW YORK CITY, NY / ACCESS Newswire / November ...
SAN JOSE, CALIFORNIA / ACCESS Newswire / November 26, 2025 / VSee Health, Inc. (NASDAQ:VSEE), a leader in innovative telemedicine solutions, today announced that it has entered into a securities ...
New Industry Aims to Create U.S. Manufacturing Jobs While Supporting Colombian Farmers Transitioning to Legal, High-Value Hemp Production CALI, COLOMBIA / ACCESS Newswire / November 26, 2025 / ...
Moderated webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Wednesday, December 3rd at 4:00 PM ET IRVINE, CA / ACCESS Newswire / November 26, 2025 / enVVeno Medical Corporation ...
ATHENS, GEORGIA / ACCESS Newswire / November 26, 2025 / In response to the devastating outbreak of Equine Herpesvirus-1 (EHV-1) linked to the WPRA event in Waco, Texas, Good Salt Life, Inc., a wholly ...
Company plans to distribute Dream Bowl 2026 Meme Coin to shareholders as of a to-be-determined December 2025 date with distribution expected in January 2026 TAMPA, FLORIDA / ACCESS Newswire / November ...
VANCOUVER, WASHINGTON / ACCESS Newswire / November 26, 2025 / Sinceri Senior Living is pleased to announce the continued expansion of its national foot, print through the transition and management of ...
Responding to the Chancellor’s Autumn Budget, Matthew Taylor, chief executive of the NHS Confederation, said:"NHS leaders across the UK understand the pressure on public finances and that's why they ...
Agreement expands NeuralCloud's AI-enhanced ECG signal-processing technology into veterinary health and elite equine performance marketsCommercial integration expands MaxYield™ and CardioYield™ ...
ESTERO, FL / ACCESS Newswire / November 26, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, ...